Loading…
← CockpitCompetitor Analysis › 6601.HK Cheerwin Group LimitedOpen in the cockpit ↗

Cheerwin Group Limited6601.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Materials›Chemicals: Agricultural
Momentum weak 35
Mkt cap
$316M
US dollars, full cap
Free float
25%
of shares outstanding
$/day
$1.12M
20-day average traded
Fwd P/E
8.1×
forward earnings
ROIC−WACC
+44.5 pp
WACC 7.6%
Hurdle
n/a
no reverse DCF
Next earnings
131 days
29 Mar 2027
Close · HKDHK$1.89
1D-0.8%
1W-0.5%
1M-18.5%
3M-16.4%
6M-19.9%
YTD-13.7%
1Y-16.7%
ATR %3.9%
52w lowhigh25.0% off high

What Cheerwin does

Employees: 1,367

Cheerwin at a glance

Size Cheerwin (6601.HK) is a Hong Kong Materials company (Chemicals: Agricultural) with a market value of $316M, the 871st largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$1.89 on 18 Nov 2026.

Performance Over six months the shares fell 19.9%, against -25.2% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue grew 25.1% over the last twelve months (peer median +2.6%); the operating margin is 9.7% (peer median 2.9%).

Valuation It trades at 8.1× forward earnings against a peer median of 11.6× (3rd cheapest of 11).

Capital Return on invested capital runs 44.5 points above its cost of capital (7.6% WACC).

Next results Next results expected around 29 Mar 2027 (exchange calendar; dates can move).

Relative performance

809010021 May 202621 Aug 202618 Nov 20266601.HK 81Peer median 76
Six months, rebased to 100: Cheerwin against the median of its 20 peers (local-currency closes).

Cheerwin financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$2.57BHK$2.16BHK$1.97BHK$1.79BHK$1.68B
Revenue growth—+9%+11%+6%—
Gross profitHK$1.39BHK$1.13BHK$970MHK$794MHK$699M
EBITDAHK$299MHK$218MHK$231MHK$165MHK$32.8M
Net incomeHK$297MHK$243MHK$221MHK$193MHK$76.9M
Free cash flowHK$223MHK$411MHK$81.1MHK$404MHK$113M
Capital expenditureHK$3.99MHK$7.59MHK$15.9MHK$16.9MHK$13.7M
Total debtn/aHK$66.1MHK$52.7MHK$30.9MHK$18.7M

Quarterly statements and history in the cockpit →

Cheerwin competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-30%-20%-10%-15%-10%-5%6050336030861708NFL300796300804600470002942ATT300575002496603970RALLISEPIGRAL600731002391603639499617126601.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Cheerwin is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%+20%10×20×30×603086300796603585300575603970RALLISEPIGRAL00239160363949966601.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Cheerwin is the large dot.

Cheerwin competitors and peer comparison

How Cheerwin compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Cheerwin against its 20 peers (data as of 18 Nov 2026)
Measure6601.HKPeer medianRank in peer set
1-month return-18.5%-13.3%lowest of 21
6-month return-19.9%-25.2%6th highest of 21
Distance from 52-week high-25.0%-37.6%3rd highest of 21
Revenue growth (TTM)+25.1%+2.6%2nd highest of 21
Operating margin9.7%2.9%4th highest of 21
Forward P/E8.1×11.6×3rd cheapest of 11
ROIC minus cost of capital+44.5 pp-0.6 pphighest of 21
Net debt / EBITDA-10.5×1.0×least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Cheerwin 6601.HKHong Kong$316M-20%+25%10%8.1×n/an/a
Shaanxi Meibang Pharmaceutical 605033.SSChina$320M-30%+15%7%n/an/an/a
Shandong CYNDA Chemical (Group) 603086.SSChina$304M-34%-4%1%6.8×n/an/a
Sesoda 1708.TWTaiwan$330M+15%+11%19%n/a-10.7%+8.8%
National Fertilizers NFL.NSIndia$332M-16%+4%3%n/an/an/a
BSM Chemical 300796.SZChina$298M-34%-5%1%23.9×n/an/a
Yingde Greatchem Chemicals 300804.SZChina$343M-27%-9%1%n/an/an/a
Anhui Liuguo Chemical 600470.SSChina$346M-29%-10%-9%n/an/an/a
Zhejiang XinNong Chemical 002942.SZChina$355M-26%+10%9%n/a5.0%-1.4%
Suli 603585.SSChina$361M-32%+1%6%9.7×n/an/a
Grupa Azoty Spolka Akcyjna ATT.WAPoland$372M-31%-3%-4%n/an/an/a
Jiangsu Flag Chemical Industry 300575.SZChina$375M-24%+21%1%26.4×0.3%+7.5%
Jiangsu Huifeng Bio Agriculture 002496.SZChina$378M-28%+40%-31%n/an/an/a
Sino-Agri Leading Biosciences 603970.SSChina$385M-23%+1%2%9.0×-11.7%+11.1%
Rallis India RALLIS.NSIndia$394M-25%+7%10%17.6×20.3%+3.6%
Epigral EPIGRAL.NSIndia$435M-24%+13%15%13.2×n/an/a
Hunan Haili Chemical Industry 600731.SSChina$438M-16%-24%11%n/a-6.6%-3.6%
Jiangsu Changqing Agrochemical 002391.SZChina$441M-25%-2%3%32.8×n/an/a
Hailir Pesticides & Chemicals 603639.SSChina$453M-24%-9%1%6.0×n/an/a
Kumiai Chemical Industry 4996.TJapan$487M-18%+7%4%10.0×-8.6%+9.7%
Sinon 1712.TWTaiwan$502M-4%+4%7%n/a-4.6%+1.3%

Questions

Which companies are Cheerwin's closest peers?
The cockpit's peer set: Shaanxi Meibang Pharmaceutical (605033.SS), Shandong CYNDA Chemical (Group) (603086.SS), Sesoda (1708.TW), National Fertilizers (NFL.NS), BSM Chemical (300796.SZ), Yingde Greatchem Chemicals (300804.SZ), Anhui Liuguo Chemical (600470.SS), Zhejiang XinNong Chemical (002942.SZ).
Is Cheerwin expensive compared with its peers?
On forward p/e it trades at 8.1× against a peer median of 11.6×, 3rd cheapest of 11 in its peer set.
How has Cheerwin stock performed?
Over six months to 18 Nov 2026 the shares returned -19.9% against -25.2% for the median peer; over one year -16.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.